Post-market lot-to-lot evaluation of the VivaDiag serological assay for COVID-19

This report contains the results of the post-market lot-to-lot evaluation of the VivaDiag serological assay for the detection of SARS-CoV-2.

Post-market lot-to-lot evaluation of the VivaDiag serological assay for COVID-19

About this resource

Publication date:
Publication type:
Report
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.